Literature DB >> 11182328

Urodynamic pattern changes in multiple sclerosis.

S J Ciancio1, S E Mutchnik, V M Rivera, T B Boone.   

Abstract

OBJECTIVES: Multiple sclerosis (MS) causes neurologic symptoms to change over time. Voiding dysfunction is common in patients with MS, and few studies have examined the changes in urodynamic patterns in these patients over time. The purpose of this study was to examine the frequency and nature of urodynamic pattern changes in patients with MS who underwent two or more urodynamic studies.
METHODS: Twenty-two patients (7 men and 15 women) with well-documented MS were referred to one urologist (T.B.B.) for evaluation of lower urinary tract symptoms. All patients had undergone two or more urodynamic evaluations during a 14-year period for persistent or new symptoms, and a retrospective comparison was made among the urodynamic test results.
RESULTS: Overall, 12 (55%) of 22 patients experienced a change in their urodynamic patterns and/or compliance during a mean follow-up interval of 42 +/- 45 months between the urodynamic studies. Most patients initially had urodynamic patterns showing detrusor hyperreflexia, detrusor external sphincter dyssynergia, or detrusor hypocontractility. Fourteen (64%) of the 22 patients studied had the same or worsening of the same symptoms and 8 (36%) of 22 had new urologic symptoms. Six (43%) of 14 patients with no new symptoms and 6 (75%) of 8 with new symptoms had significant changes found with follow-up urodynamic testing.
CONCLUSIONS: A significant proportion of patients with MS with and without new urinary symptoms will develop changes in their underlying urodynamic patterns and detrusor compliance. Therefore, urodynamic evaluations should be repeated at regular intervals in symptomatic patients to optimize clinical management, reduce complications, and better enable these patients to manage their neurogenic bladder dysfunction.

Entities:  

Mesh:

Year:  2001        PMID: 11182328     DOI: 10.1016/s0090-4295(00)01070-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  22 in total

Review 1.  Vesicourethral dysfunction in multiple sclerosis. Initial assessment based on lower urinary tract symptoms and their pathophysiology.

Authors:  Paolo Di Benedetto; Cristina Delneri; Emanuele Biasutti; Luisa Monti Bragadin; Tullio Giorgini
Journal:  Neurol Sci       Date:  2008-12       Impact factor: 3.307

Review 2.  Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.

Authors:  Oussama El Yazami Adli; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2014-01       Impact factor: 1.862

3.  Videourodynamics in patients with neurogenic bladder due to multiple sclerosis: our experience.

Authors:  D Caramella; G Donatelli; N Armillotta; F Manassero; C Traversi; P Frumento; D Pistolesi; C Selli
Journal:  Radiol Med       Date:  2011-01-12       Impact factor: 3.469

4.  Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Zhibo Jin; Yinghui Ding; Rui Xue; Zhankui Jia; Zhenlin Huang; Yafei Ding; Chaohui Gu; Jinjian Yang
Journal:  Int Urol Nephrol       Date:  2017-04-19       Impact factor: 2.370

Review 5.  Neurogenic lower urinary tract dysfunction: evaluation and management.

Authors:  Katarina Ivana Tudor; Ryuji Sakakibara; Jalesh N Panicker
Journal:  J Neurol       Date:  2016-07-11       Impact factor: 4.849

Review 6.  Inflammation induced neurological handicap processes in multiple sclerosis: new insights from preclinical studies.

Authors:  Klaus G Petry; Bruno Brochet; Vincent Dousset; Jean Rodolphe Vignes; Claudine Boiziau
Journal:  J Neural Transm (Vienna)       Date:  2010-06-23       Impact factor: 3.575

7.  Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats.

Authors:  Jean-Rodolphe Vignes; Mathilde S A Deloire; Klaus G Petry; Frédéric Nagy
Journal:  J Physiol       Date:  2006-10-26       Impact factor: 5.182

8.  A Framework of Care in Multiple Sclerosis, Part 2: Symptomatic Care and Beyond.

Authors:  Scott D Newsome; Philip J Aliotta; Jacquelyn Bainbridge; Susan E Bennett; Gary Cutter; Kaylan Fenton; Fred Lublin; Dorothy Northrop; David Rintell; Bryan D Walker; Megan Weigel; Kathleen Zackowski; David E Jones
Journal:  Int J MS Care       Date:  2017 Jan-Feb

Review 9.  Surveillance urodynamics for neurogenic lower urinary tract dysfunction: A systematic review.

Authors:  Alex Kavanagh; Hamed Akhavizadegan; Matthias Walter; Lynn Stothers; Blayne Welk; Timothy B Boone
Journal:  Can Urol Assoc J       Date:  2018-12-03       Impact factor: 1.862

Review 10.  Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients.

Authors:  Areeba Sadiq; Benjamin M Brucker
Journal:  Curr Urol Rep       Date:  2015-07       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.